Takeda, Sweden-based Karolinska Institutet and The Structural Genomics Consortium entered into a precompetitive and proprietary collaboration agreement to research and test potential intervention points for inflammatory bowel disease.
Takeda Pharmaceuticals U.S.A. donated $100,000 to local and regional nonprofits as part of its annual Takeda Cares Day.
EnteroMedics acquired ReShape Medical and its ReShape Dual Weight Loss Balloon, a minimally invasive intragastric balloon system.
TransMed7, a medical device company, appointed Michael Demeure, MD, chair of its endocrine and gastrointestinal health team.
More articles on gastroenterology:
Allergan under scrutiny for Restasis patent transfer — 4 insights
GI leader to know: Dr. Gary Varilek of Gastroenterology Specialties
Stock market week-in-review for 5 large GI companies — Oct. 2-6
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
